Acadia Healthcare (NASDAQ:ACHC) Reaches New 52-Week Low – Should You Sell?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price reached a new 52-week low on Friday . The company traded as low as $41.11 and last traded at $41.34, with a volume of 115133 shares changing hands. The stock had previously closed at $42.08.

Analyst Upgrades and Downgrades

ACHC has been the subject of several research analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research report on Friday, September 20th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. KeyCorp began coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Barclays reduced their price target on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a report on Monday, September 30th. Finally, StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Monday. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $86.67.

Acadia Healthcare Trading Down 2.3 %

The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The business’s 50-day moving average is $62.78 and its two-hundred day moving average is $67.01. The stock has a market capitalization of $3.82 billion, a PE ratio of 13.80, a PEG ratio of 1.87 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.91 earnings per share. On average, analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the stock. William Blair Investment Management LLC raised its position in shares of Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after purchasing an additional 604,070 shares during the period. Point72 Asset Management L.P. lifted its holdings in Acadia Healthcare by 266.0% during the 2nd quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after buying an additional 1,650,040 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in Acadia Healthcare by 6.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock worth $84,382,000 after acquiring an additional 77,509 shares during the period. Millennium Management LLC raised its holdings in Acadia Healthcare by 3,067.8% in the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock worth $73,640,000 after purchasing an additional 1,055,894 shares during the period. Finally, Iron Triangle Partners LP raised its holdings in Acadia Healthcare by 14.0% during the 1st quarter. Iron Triangle Partners LP now owns 902,813 shares of the company’s stock worth $71,521,000 after buying an additional 110,820 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.